FLUOROMETRIC ASSAY OF CHYMOPAPAIN

摘要

A method for identifying and quantifying chymopapain-specific lgE antibody levels in patient serum comprising binding chymopapain-specific lgE, if any, in the serum with chymopapain adhering to an insoluble support, conjugating the serum lgE with a labeled anti-lgE antibody, and measuring the level of labeled compound bound to the insoluble support or in the solution removed therefrom. Special reagents and their manufacture are also disclosed.